Drug Metabolism/Pharmacology

Top Story

BioIVT research links BSEP inhibition with bile acid suppression in DILI

September 12, 2018
In the Journals

Multimorbidity most significant risk factor for polypharmacy in older patients

August 15, 2018
Patients aged 75 to 85 years with more than eight diagnosed diseases or conditions were at the highest risk for polypharmacy, according to findings recently published in…
In the Journals

Expert strategy identifies etiology in indeterminate acute liver failure cases

July 12, 2018
Researchers were able to establish an etiologic diagnosis among nearly 50% of patients with previously indeterminate etiology of acute liver failure using a systematic…
Meeting News

Healio live from EASL’s 2018 International Liver Congress

April 11, 2018
PARIS — Beginning Wednesday, April 11, Healio Gastroenterology and Liver Disease will provide live coverage from the International Liver Congress 2018. Held from…
More Headlines »

Cirrhosis and Hepatic Encephalopathy – Managing Their Consequences and Complications

This activity is supported by an educational grant from Salix Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC.

Cirrhosis, or advanced fibrosis of the liver, can lead to serious health sequelae or death. However, substantial…
More »
GI Bookshelf

Question 37: Which Asymptomatic Patients With Cirrhosis Should Undergo An Upper Endoscopy To Determine Whether They Have Esophageal Varices?

From Curbside Consultation of the Liver: 49 Clinical Questions
More »
Resource Centers
International Liver Congress

International Liver Congress

Meeting News

VIDEO: Physicians must directly discuss complementary medications

November 16, 2017
More »